145 related articles for article (PubMed ID: 35869775)
1. [Impact of multi-leaf collimator positioning accuracy on quality control of volumetric modulation arc therapy plan for cervical cancer treated with Elekta linear accelerator].
Liang J; Yu F; Zhu J; Song T
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jul; 42(7):1089-1094. PubMed ID: 35869775
[TBL] [Abstract][Full Text] [Related]
2. Analysis of direct clinical consequences of MLC positional errors in volumetric-modulated arc therapy using 3D dosimetry system.
Nithiyanantham K; Mani GK; Subramani V; Mueller L; Palaniappan KK; Kataria T
J Appl Clin Med Phys; 2015 Sep; 16(5):296–305. PubMed ID: 26699311
[TBL] [Abstract][Full Text] [Related]
3. Correlation Between Average Segment Width and Gamma Passing Rate as a Function of MLC Position Error in Volumetric Modulated Arc Therapy.
Moon YM; Bae SI; Han MJ; Jeon W; Yu T; Choi CW; Kim JY
Technol Cancer Res Treat; 2021; 20():15330338211059937. PubMed ID: 34821195
[TBL] [Abstract][Full Text] [Related]
4. Description and evaluation of a new volumetric-modulated arc therapy plan complexity metric.
Li G; Jiang W; Li Y; Wang Q; Xiao J; Zhong R; Bai S
Med Dosim; 2021 Summer; 46(2):188-194. PubMed ID: 33353791
[TBL] [Abstract][Full Text] [Related]
5. Texture analysis on the fluence map to evaluate the degree of modulation for volumetric modulated arc therapy.
Park SY; Kim IH; Ye SJ; Carlson J; Park JM
Med Phys; 2014 Nov; 41(11):111718. PubMed ID: 25370632
[TBL] [Abstract][Full Text] [Related]
6. Quality assurance of non-coplanar, volumetric-modulated arc therapy employing a C-arm linear accelerator, featuring continuous patient couch rotation.
Hirashima H; Nakamura M; Miyabe Y; Mukumoto N; Ono T; Iramina H; Mizowaki T
Radiat Oncol; 2019 Apr; 14(1):62. PubMed ID: 30971273
[TBL] [Abstract][Full Text] [Related]
7. Modulation indices and plan delivery accuracy of volumetric modulated arc therapy.
Park JM; Kim JI; Park SY
J Appl Clin Med Phys; 2019 Jun; 20(6):12-22. PubMed ID: 31038843
[TBL] [Abstract][Full Text] [Related]
8. Determination of MLC model parameters for Monaco using commercial diode arrays.
Kinsella P; Shields L; McCavana P; McClean B; Langan B
J Appl Clin Med Phys; 2016 Jul; 17(4):37-47. PubMed ID: 27455495
[TBL] [Abstract][Full Text] [Related]
9. A novel method for routine quality assurance of volumetric-modulated arc therapy.
Wang Q; Dai J; Zhang K
Med Phys; 2013 Oct; 40(10):101712. PubMed ID: 24089902
[TBL] [Abstract][Full Text] [Related]
10. A generalized inverse planning tool for volumetric-modulated arc therapy.
Cao D; Afghan MK; Ye J; Chen F; Shepard DM
Phys Med Biol; 2009 Nov; 54(21):6725-38. PubMed ID: 19841516
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the modulation degrees of intensity-modulated radiation therapy plans.
Park SY; Kim JI; Chun M; Ahn H; Park JM
Radiat Oncol; 2018 Dec; 13(1):244. PubMed ID: 30545396
[TBL] [Abstract][Full Text] [Related]
12. Comparison of DVH-based plan verification methods for VMAT: ArcCHECK-3DVH system and dynalog-based dose reconstruction.
Saito M; Kadoya N; Sato K; Ito K; Dobashi S; Takeda K; Onishi H; Jingu K
J Appl Clin Med Phys; 2017 Jul; 18(4):206-214. PubMed ID: 28649722
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of MLC leaf positioning accuracy for static and dynamic IMRT treatments using DAVID in vivo dosimetric system.
Karagoz G; Zorlu F; Yeginer M; Yildiz D; Ozyigit G
J Appl Clin Med Phys; 2016 Mar; 17(2):14-23. PubMed ID: 27074451
[TBL] [Abstract][Full Text] [Related]
14. Quantitative evaluation of 3D dosimetry for stereotactic volumetric-modulated arc delivery using COMPASS.
Vikraman S; Manigandan D; Karrthick KP; Sambasivaselli R; Senniandavar V; Ramu M; Rajesh T; Lutz M; Muthukumaran M; Karthikeyan N; Tejinder K
J Appl Clin Med Phys; 2014 Jan; 16(1):5128. PubMed ID: 25679152
[TBL] [Abstract][Full Text] [Related]
15. Dynamic positioning accuracy of a novel multileaf collimator for volumetric modulated arc therapy.
Nakaguchi Y; Ono T; Onizuka R; Maruyama M; Shimohigashi Y; Kai Y
Radiol Phys Technol; 2016 Jan; 9(1):121-6. PubMed ID: 26612534
[TBL] [Abstract][Full Text] [Related]
16. A method to reconstruct and apply 3D primary fluence for treatment delivery verification.
Liu S; Mazur TR; Li H; Curcuru A; Green OL; Sun B; Mutic S; Yang D
J Appl Clin Med Phys; 2017 Jan; 18(1):128-138. PubMed ID: 28291913
[TBL] [Abstract][Full Text] [Related]
17. Do technological advances in linear accelerators improve dosimetric outcomes in stereotaxy? A head-on comparison of seven linear accelerators using volumetric modulated arc therapy-based stereotactic planning.
Sarkar B; Pradhan A; Munshi A
Indian J Cancer; 2016; 53(1):166-73. PubMed ID: 27146771
[TBL] [Abstract][Full Text] [Related]
18. Correlation between gamma index passing rate and clinical dosimetric difference for pre-treatment 2D and 3D volumetric modulated arc therapy dosimetric verification.
Jin X; Yan H; Han C; Zhou Y; Yi J; Xie C
Br J Radiol; 2015 Mar; 88(1047):20140577. PubMed ID: 25494412
[TBL] [Abstract][Full Text] [Related]
19. Validation of a new control system for Elekta accelerators facilitating continuously variable dose rate.
Bertelsen A; Lorenzen EL; Brink C
Med Phys; 2011 Aug; 38(8):4802-10. PubMed ID: 21928653
[TBL] [Abstract][Full Text] [Related]
20. Impact of plan parameters on the dosimetric accuracy of volumetric modulated arc therapy.
Masi L; Doro R; Favuzza V; Cipressi S; Livi L
Med Phys; 2013 Jul; 40(7):071718. PubMed ID: 23822422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
